Treatment of Nontuberculous Mycobacterial Pulmonary Infections

This is first update of U.S. guidelines on management of nontuberculous mycobacterial pulmonary disease in 13 years.

Sponsoring Organizations: The American Thoracic Society (ATS), the Infectious Diseases Society of America (IDSA), the European Respiratory Society, and the European Society of Clinical Microbiology and Infectious Diseases

Target Audience: Infectious disease specialists, pulmonary specialists, thoracic surgeons

Background and Objective

This update of 2007 ATS/IDSA guidelines on the diagnosis, treatment, and prevention of nontuberculous mycobacterial (NTM) infections focuses on treatment of NTM pulmonary disease in patients without HIV or cystic fibrosis.

Key Points

Begin treatment in individuals who have ≥2 positive mycobacterial cultures for the same species, as opposed to watchful waiting. When possible, guide therapy using susceptibility d…

Reviewing Author

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health